{
    "name": "Oncogenic Mutations Range Alias",
    "description": "Custom Description",
    "start": 599,
    "end": 700,
    "oncogenicities": [
        {
            "oncogenicity": "YES"
        },
        {
            "oncogenicity": "LIKELY"
        }
    ],
    "mutationTypes": [],
    "evidences": [
        {
            "id": 21742,
            "uuid": "e60b0c6b-3c55-4bc1-b07a-ddc2b867c2bd",
            "evidenceType": "PROGNOSTIC_IMPLICATION",
            "cancerTypes": [
                {
                    "id": 494,
                    "subtype": "Acute Leukemias of Ambiguous Lineage",
                    "code": "ALAL",
                    "color": "LightSalmon",
                    "mainType": "Leukemia",
                    "level": 3,
                    "tissue": "Myeloid",
                    "tumorForm": "LIQUID"
                }
            ],
            "excludedCancerTypes": [],
            "relevantCancerTypes": [],
            "gene": {
                "entrezGeneId": 673,
                "hugoSymbol": "BRAF",
                "geneType": "ONCOGENE",
                "grch37Isoform": "ENST00000288602",
                "grch37RefSeq": "",
                "grch38Isoform": "ENST00000646891",
                "grch38RefSeq": "",
                "geneAliases": [
                    "BRAF1"
                ],
                "genesets": []
            },
            "alterations": [],
            "name": null,
            "description": "Prognostic test 1",
            "additionalInfo": null,
            "treatments": [],
            "knownEffect": null,
            "lastEdit": 1769641714000,
            "lastReview": null,
            "levelOfEvidence": "LEVEL_Px1",
            "fdaLevel": null,
            "solidPropagationLevel": null,
            "liquidPropagationLevel": null,
            "articles": []
        },
        {
            "id": 21744,
            "uuid": "5a6d5157-f715-4367-a6eb-6b2acab67386",
            "evidenceType": "DIAGNOSTIC_IMPLICATION",
            "cancerTypes": [
                {
                    "id": 494,
                    "subtype": "Acute Leukemias of Ambiguous Lineage",
                    "code": "ALAL",
                    "color": "LightSalmon",
                    "mainType": "Leukemia",
                    "level": 3,
                    "tissue": "Myeloid",
                    "tumorForm": "LIQUID"
                }
            ],
            "excludedCancerTypes": [],
            "relevantCancerTypes": [
                {
                    "id": 494,
                    "subtype": "Acute Leukemias of Ambiguous Lineage",
                    "code": "ALAL",
                    "color": "LightSalmon",
                    "mainType": "Leukemia",
                    "level": 3,
                    "tissue": "Myeloid",
                    "tumorForm": "LIQUID"
                }
            ],
            "gene": {
                "entrezGeneId": 673,
                "hugoSymbol": "BRAF",
                "geneType": "ONCOGENE",
                "grch37Isoform": "ENST00000288602",
                "grch37RefSeq": "",
                "grch38Isoform": "ENST00000646891",
                "grch38RefSeq": "",
                "geneAliases": [
                    "BRAF1"
                ],
                "genesets": []
            },
            "alterations": [],
            "name": null,
            "description": "Diagnostic Test 1",
            "additionalInfo": null,
            "treatments": [],
            "knownEffect": null,
            "lastEdit": 1769641680000,
            "lastReview": null,
            "levelOfEvidence": "LEVEL_Dx1",
            "fdaLevel": null,
            "solidPropagationLevel": null,
            "liquidPropagationLevel": null,
            "articles": []
        },
        {
            "id": 21745,
            "uuid": "2c85304e-9395-450e-aa0a-e0b1ee06c357",
            "evidenceType": "STANDARD_THERAPEUTIC_IMPLICATIONS_FOR_DRUG_SENSITIVITY",
            "cancerTypes": [
                {
                    "id": 494,
                    "subtype": "Acute Leukemias of Ambiguous Lineage",
                    "code": "ALAL",
                    "color": "LightSalmon",
                    "mainType": "Leukemia",
                    "level": 3,
                    "tissue": "Myeloid",
                    "tumorForm": "LIQUID"
                }
            ],
            "excludedCancerTypes": [],
            "relevantCancerTypes": [],
            "gene": {
                "entrezGeneId": 673,
                "hugoSymbol": "BRAF",
                "geneType": "ONCOGENE",
                "grch37Isoform": "ENST00000288602",
                "grch37RefSeq": "",
                "grch38Isoform": "ENST00000646891",
                "grch38RefSeq": "",
                "geneAliases": [
                    "BRAF1"
                ],
                "genesets": []
            },
            "alterations": [],
            "name": null,
            "description": "Test 1",
            "additionalInfo": null,
            "treatments": [
                {
                    "approvedIndications": [],
                    "priority": 1,
                    "drugs": [
                        {
                            "ncitCode": "C49176",
                            "drugName": "Palbociclib",
                            "priority": 1
                        }
                    ]
                }
            ],
            "knownEffect": "Sensitive",
            "lastEdit": 1769631407000,
            "lastReview": null,
            "levelOfEvidence": "LEVEL_1",
            "fdaLevel": "LEVEL_Fda2",
            "solidPropagationLevel": "LEVEL_3B",
            "liquidPropagationLevel": "LEVEL_3B",
            "articles": []
        }
    ],
    "highestLevels": {
        "highestSensitiveLevel": "LEVEL_1",
        "highestResistanceLevel": null,
        "highestDiagnosticLevel": "LEVEL_Dx1",
        "highestPrognosticLevel": "LEVEL_Px1",
        "highestFDALevel": "LEVEL_Fda2"
    }
}